PT93488A - Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina - Google Patents

Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina

Info

Publication number
PT93488A
PT93488A PT93488A PT9348890A PT93488A PT 93488 A PT93488 A PT 93488A PT 93488 A PT93488 A PT 93488A PT 9348890 A PT9348890 A PT 9348890A PT 93488 A PT93488 A PT 93488A
Authority
PT
Portugal
Prior art keywords
alpha
pregn
hydroxy
methyl
pure
Prior art date
Application number
PT93488A
Other languages
English (en)
Other versions
PT93488B (pt
Inventor
Gerard Arnoud Josef Maria Sas
Emile Martin Van Doornum
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT93488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of PT93488A publication Critical patent/PT93488A/pt
Publication of PT93488B publication Critical patent/PT93488B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT93488A 1989-03-18 1990-03-16 Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina PT93488B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900673 1989-03-18

Publications (2)

Publication Number Publication Date
PT93488A true PT93488A (pt) 1990-11-07
PT93488B PT93488B (pt) 1996-02-29

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93488A PT93488B (pt) 1989-03-18 1990-03-16 Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina

Country Status (17)

Country Link
US (1) US5037817A (pt)
EP (1) EP0389035B1 (pt)
JP (2) JP3139709B2 (pt)
KR (1) KR0183401B1 (pt)
AT (1) ATE98490T1 (pt)
AU (1) AU625083B2 (pt)
CA (1) CA2011452C (pt)
DE (1) DE69005165T2 (pt)
DK (1) DK0389035T3 (pt)
ES (1) ES2062292T3 (pt)
FI (1) FI94865C (pt)
HK (1) HK1002019A1 (pt)
IE (1) IE63051B1 (pt)
MX (1) MX9203787A (pt)
NZ (1) NZ232946A (pt)
PT (1) PT93488B (pt)
ZA (1) ZA901674B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
SK284569B6 (sk) * 1998-10-16 2005-06-02 Akzo Nobel N.V. Vysoko čistá zlúčenina (7alfa, 17alfa)-17-hydroxy-7-metyl-19-nor- 17-pregn-5(10)-én-20-ín-3-ón, spôsob jej prípravy a farmaceutická dávková jednotka s jej obsahom
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
AU779138B2 (en) * 1999-03-18 2005-01-06 Genelabs Technologies, Inc. DHEA composition and method
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
ATE364619T1 (de) * 2001-10-18 2007-07-15 Norton Healthcare Ltd Tibolonformulierungen
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
KR20040073572A (ko) * 2002-01-22 2004-08-19 악조 노벨 엔.브이. 내인성 에스트로겐의 합성을 예방하는 약물의 투여와관련된 호소 증상의 치료에서의 티볼론
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
AU2004203420B8 (en) * 2003-05-23 2008-02-21 N.V. Organon Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
WO2006125453A1 (en) * 2005-05-23 2006-11-30 Newchem S.P.A. Process for the preparation of pure crystalline tibolone
EP1821571A1 (en) * 2006-02-15 2007-08-22 Oticon A/S Loop antenna for in the ear audio device
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
WO2017191266A1 (en) 2016-05-04 2017-11-09 Mithra Pharmaceuticals S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (pt) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
KR0183401B1 (ko) 1999-05-01
ZA901674B (en) 1990-12-28
MX9203787A (es) 1992-07-01
JP2001139473A (ja) 2001-05-22
DE69005165T2 (de) 1994-05-05
EP0389035A1 (en) 1990-09-26
EP0389035B1 (en) 1993-12-15
ES2062292T3 (es) 1994-12-16
CA2011452C (en) 1999-05-25
AU625083B2 (en) 1992-07-02
DE69005165D1 (de) 1994-01-27
ATE98490T1 (de) 1994-01-15
JP3139709B2 (ja) 2001-03-05
DK0389035T3 (da) 1994-02-14
KR900013950A (ko) 1990-10-22
AU5139490A (en) 1990-09-20
JPH0347195A (ja) 1991-02-28
IE900709L (en) 1990-09-18
FI94865B (fi) 1995-07-31
PT93488B (pt) 1996-02-29
US5037817A (en) 1991-08-06
IE63051B1 (en) 1995-03-22
HK1002019A1 (en) 1998-07-24
NZ232946A (en) 1991-08-27
FI901328A0 (fi) 1990-03-16
FI94865C (fi) 1995-11-10
CA2011452A1 (en) 1990-09-18

Similar Documents

Publication Publication Date Title
FI903429A0 (fi) Kompositioner av vattenloesliga peptider med foerdroejd frigoering.
MX9203787A (es) Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
IT8721365A0 (it) Dentiere. composizioni resinose per base di
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
IT1246445B (it) Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.
NO912992L (no) 1-aminopropandiol-2,3 med hoey renhet, samt fremgangsmaate for fremstilling av forbindelsen.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
ITMI910284A0 (it) Processo per la preparazione di 2,2,6,6-tetrametil-4-piperidilammine
ITMI910320A1 (it) Processo per la preaparazione di 1. 3-diossoli
IT8747551A0 (it) 8 alfa acilamminoergoline ,loro preparazione e loro impiego come medicamenti
DE69012882D1 (de) Herstellung von Stickstoffzusammensetzungen.
PT84750B (pt) Processo de preparacao de uma composicao para o envenenamento de roedores, a base de derivados de 1,4-naftoquinona
IT1216056B (it) Composizioni farmaceutiche contenenti timosina alfa 1.
NO892147D0 (no) Analogifremgangsmaate for fremstilling av 1,2-dithiol-3-thion-s-oxyd-forbindelser med farmakologiske egenskaper.
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
ES2061667T3 (es) Agente hipotensivo para el tratamiento o prevencion de la hipertension.
IT1247618B (it) Procedimento per la fabbricazione di rivestimenti decorativi per i mobili d'arredamento
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
FI901046A7 (fi) Polyprenyyliyhdisteen stabiloiminen
IT8919651A0 (it) Tavolo ad elevata flessibilita' di composizione.
IT8619891A0 (it) Procedimento per la monosolfonazione di composti finilindanici e composizioni cosi'ottenute.
IT8621925A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
ATE90942T1 (de) (3-diethylaminopropyl)-1-amino-5methyldipyrido(4,3-b>(3,4-f>indoltrihydrochlori .
IT8821386A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19951120

PC4A Transfer of assignment

Owner name: N.V. ORGANON, NL

Effective date: 20061124

PD4A Change of proprietorship

Owner name: AKZO NOBEL N.V., NL

Effective date: 20061124

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20101122